vs
Side-by-side financial comparison of PLAYSTUDIOS, Inc. (MYPS) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $55.4M, roughly 1.4× PLAYSTUDIOS, Inc.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -24.7%, a 32.1% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -18.3%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $3.6M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -15.6%).
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
MYPS vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $76.2M |
| Net Profit | $-13.7M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | -17.7% | 11.0% |
| Net Margin | -24.7% | 7.4% |
| Revenue YoY | -18.3% | 25.5% |
| Net Profit YoY | 38.9% | 30.7% |
| EPS (diluted) | $-0.12 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $76.2M | ||
| Q3 25 | $57.6M | $71.9M | ||
| Q2 25 | $59.3M | $63.1M | ||
| Q1 25 | $62.7M | $59.1M | ||
| Q4 24 | $67.8M | $60.7M | ||
| Q3 24 | $71.2M | $58.0M | ||
| Q2 24 | $72.6M | $55.0M | ||
| Q1 24 | $77.8M | $50.6M |
| Q4 25 | $-13.7M | $5.6M | ||
| Q3 25 | $-9.1M | $3.5M | ||
| Q2 25 | $-2.9M | $3.2M | ||
| Q1 25 | $-2.9M | $2.6M | ||
| Q4 24 | $-22.4M | $4.3M | ||
| Q3 24 | $-3.1M | $3.9M | ||
| Q2 24 | $-2.6M | $1.5M | ||
| Q1 24 | $-567.0K | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | -17.7% | 11.0% | ||
| Q3 25 | -13.6% | 7.8% | ||
| Q2 25 | -5.9% | 8.1% | ||
| Q1 25 | -4.4% | 6.5% | ||
| Q4 24 | -33.1% | 10.6% | ||
| Q3 24 | -6.7% | 9.7% | ||
| Q2 24 | -5.5% | 6.6% | ||
| Q1 24 | -2.2% | 4.4% |
| Q4 25 | -24.7% | 7.4% | ||
| Q3 25 | -15.8% | 4.9% | ||
| Q2 25 | -5.0% | 5.0% | ||
| Q1 25 | -4.6% | 4.4% | ||
| Q4 24 | -33.1% | 7.1% | ||
| Q3 24 | -4.3% | 6.7% | ||
| Q2 24 | -3.6% | 2.7% | ||
| Q1 24 | -0.7% | 3.2% |
| Q4 25 | $-0.12 | $0.14 | ||
| Q3 25 | $-0.07 | $0.09 | ||
| Q2 25 | $-0.02 | $0.08 | ||
| Q1 25 | $-0.02 | $0.06 | ||
| Q4 24 | $-0.18 | $0.10 | ||
| Q3 24 | $-0.02 | $0.10 | ||
| Q2 24 | $-0.02 | $0.04 | ||
| Q1 24 | $0.00 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.9M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $227.9M | $141.5M |
| Total Assets | $290.6M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.9M | $13.5M | ||
| Q3 25 | $106.3M | $11.1M | ||
| Q2 25 | $112.9M | $20.0M | ||
| Q1 25 | $107.1M | $10.2M | ||
| Q4 24 | $109.2M | $17.5M | ||
| Q3 24 | $105.2M | $11.3M | ||
| Q2 24 | $106.3M | $8.8M | ||
| Q1 24 | $127.0M | $7.3M |
| Q4 25 | $227.9M | $141.5M | ||
| Q3 25 | $238.9M | $133.6M | ||
| Q2 25 | $245.3M | $139.7M | ||
| Q1 25 | $244.1M | $134.8M | ||
| Q4 24 | $244.7M | $131.4M | ||
| Q3 24 | $265.2M | $125.0M | ||
| Q2 24 | $263.6M | $119.4M | ||
| Q1 24 | $288.4M | $116.3M |
| Q4 25 | $290.6M | $199.2M | ||
| Q3 25 | $299.2M | $202.4M | ||
| Q2 25 | $316.2M | $184.6M | ||
| Q1 25 | $313.8M | $178.1M | ||
| Q4 24 | $323.0M | $177.1M | ||
| Q3 24 | $330.6M | $169.5M | ||
| Q2 24 | $333.4M | $163.9M | ||
| Q1 24 | $357.5M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.7M | $18.4M |
| Free Cash FlowOCF − Capex | $3.6M | $9.7M |
| FCF MarginFCF / Revenue | 6.5% | 12.7% |
| Capex IntensityCapex / Revenue | 0.2% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $25.4M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.7M | $18.4M | ||
| Q3 25 | $5.7M | $18.4M | ||
| Q2 25 | $13.6M | $12.3M | ||
| Q1 25 | $3.3M | $2.9M | ||
| Q4 24 | $11.6M | $15.0M | ||
| Q3 24 | $14.6M | $12.7M | ||
| Q2 24 | $14.5M | $10.2M | ||
| Q1 24 | $5.0M | $1.2M |
| Q4 25 | $3.6M | $9.7M | ||
| Q3 25 | $5.4M | $10.7M | ||
| Q2 25 | $13.2M | $4.1M | ||
| Q1 25 | $3.2M | $-12.6M | ||
| Q4 24 | $11.5M | $3.2M | ||
| Q3 24 | $13.9M | $1.7M | ||
| Q2 24 | $12.8M | $1.2M | ||
| Q1 24 | $3.6M | $-4.8M |
| Q4 25 | 6.5% | 12.7% | ||
| Q3 25 | 9.3% | 14.9% | ||
| Q2 25 | 22.3% | 6.5% | ||
| Q1 25 | 5.1% | -21.4% | ||
| Q4 24 | 16.9% | 5.2% | ||
| Q3 24 | 19.6% | 3.0% | ||
| Q2 24 | 17.6% | 2.3% | ||
| Q1 24 | 4.6% | -9.5% |
| Q4 25 | 0.2% | 11.5% | ||
| Q3 25 | 0.5% | 10.6% | ||
| Q2 25 | 0.7% | 12.9% | ||
| Q1 25 | 0.2% | 26.2% | ||
| Q4 24 | 0.2% | 19.5% | ||
| Q3 24 | 0.9% | 19.0% | ||
| Q2 24 | 2.4% | 16.3% | ||
| Q1 24 | 1.9% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
